Ophthotech reported $329.48M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alimera Sciences ALIM:US USD 29.76M 3.31M
Cytrx CYTR:US USD 6.18M 2.1M
Insmed INSM:US USD 632.16M 42.56M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Novartis NOVN:VX USD 36.95B 1.19B
Ophthotech OPHT:US USD 329.48M 12.26M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Roche Holding ROG:VX 30.32B 5.31B